Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| γδ T cells: origin and fate, subsets, diseases and immunotherapy. | Signal Transduct Target Ther | 2023 | 37989744 | PubTator, text mining | PubMed |
| Third-generation rabies viral vectors allow nontoxic retrograde targeting of projection neurons with greatly increased efficiency. | Cell Rep Methods | 2023 | 37989085 | PubTator, text mining | PubMed |
| EDIII-Fc induces protective immune responses against the Zika virus in mice and rhesus macaque. | PLoS Negl Trop Dis | 2023 | 37983259 | PubTator, text mining | PubMed |
| Near obstructing painful anorectal mass and facial rash in a man with monkeypox: A case report. | World J Clin Cases | 2023 | 37969438 | PubTator, text mining | PubMed |
| Transcript Isoform Diversity of Ampliconic Genes on the Y Chromosome of Great Apes. | Genome Biol Evol | 2023 | 37967251 | PubTator, text mining | PubMed |
| Clonal redemption of B cells in cancer. | Front Immunol | 2023 | 37965337 | PubTator, text mining | PubMed |
| Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein. | Int J Mol Sci | 2023 | 37958877 | PubTator, text mining | PubMed |
| RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity. | Cell Rep Med | 2023 | 37944530 | PubTator, text mining | PubMed |
| Hepatitis B doubly spliced protein (HBDSP) promotes hepatocellular carcinoma cell apoptosis via ETS1/GATA2/YY1-mediated p53 transcription. | J Virol | 2023 | 37929990 | PubTator, text mining | PubMed |
| Intronic Variants of the Angiotensin-Converting Enzyme 2 Gene Modulate Plasma ACE2 Levels and Possibly Confer Protection against Severe COVID-19. | Biomed Res Int | 2023 | 37929242 | PubTator, text mining | PubMed |
| From Emergence to Endemicity: A Comprehensive Review of COVID-19. | Cureus | 2023 | 37916248 | PubTator, text mining | PubMed |
| Immunoinformatic exploration of a multi-epitope-based peptide vaccine candidate targeting emerging variants of SARS-CoV-2. | Front Microbiol | 2023 | 37915849 | PubTator, text mining | PubMed |
| Retroviral hijacking of host transport pathways for genome nuclear export. | mBio | 2023 | 37909783 | PubTator, text mining | PubMed |
| The Ubiquitin-Proteasome System Facilitates Membrane Fusion and Uncoating during Coronavirus Entry. | Viruses | 2023 | 37896778 | PubTator, text mining | PubMed |
| Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies. | Pharmaceuticals (Basel) | 2023 | 37895950 | PubTator, text mining | PubMed |
Heparin Precursors with Reduced Anticoagulant Properties Retain Antiviral and Protective Effects That Potentiate the Efficacy of Sofosbuvir against Zika Virus Infection in Human Neural Progenitor Cells. | Pharmaceuticals (Basel) | 2023 | 37895856 | PubTator, text mining | PubMed |
| Molecular Characterization of Complete Genome Sequence of an Avian Coronavirus Identified in a Backyard Chicken from Tanzania. | Genes (Basel) | 2023 | 37895200 | PubTator, text mining | PubMed |
| A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis. | Int J Mol Sci | 2023 | 37894850 | PubTator, text mining | PubMed |
| Intervention Effects of Physical Activity on Type 2 Diabetic Patients Potentially Infected with COVID-19. | Medicina (Kaunas) | 2023 | 37893490 | PubTator, text mining | PubMed |
| Unraveling the Link between Periodontitis and Coronavirus Disease 2019: Exploring Pathogenic Pathways and Clinical Implications. | Biomedicines | 2023 | 37893162 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=13